Justin Bowers
Stock Analyst at Wells Fargo
(1.92)
# 3,179
Out of 5,124 analysts
42
Total ratings
40%
Success rate
4.71%
Average return
Main Sectors:
Stocks Rated by Justin Bowers
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FLUT Flutter Entertainment | Initiates: Overweight | $272 | $215.04 | +26.49% | 1 | Nov 18, 2025 | |
| DKNG DraftKings | Initiates: Equal-Weight | $31 | $34.46 | -10.04% | 1 | Nov 18, 2025 | |
| WAT Waters | Maintains: Hold | $375 → $315 | $379.83 | -17.07% | 4 | Aug 5, 2025 | |
| MEDP Medpace Holdings | Maintains: Hold | $270 → $430 | $561.65 | -23.44% | 3 | Jul 23, 2025 | |
| IQV IQVIA Holdings | Maintains: Buy | $270 → $265 | $225.41 | +17.56% | 2 | Nov 1, 2024 | |
| FTRE Fortrea Holdings | Maintains: Hold | $28 → $23 | $17.25 | +33.33% | 3 | Aug 20, 2024 | |
| CON Concentra Group Holdings Parent | Initiates: Buy | $29 | $19.68 | +47.36% | 1 | Aug 19, 2024 | |
| TXG 10x Genomics | Downgrades: Hold | $55 → $25 | $16.31 | +53.28% | 3 | Jul 10, 2024 | |
| RGEN Repligen | Upgrades: Buy | $180 → $155 | $163.86 | -5.41% | 2 | Jun 26, 2024 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $600 → $610 | $579.45 | +5.27% | 3 | Apr 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $85 → $82 | $58.81 | +39.43% | 2 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $23 → $25 | $11.46 | +118.15% | 3 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $17 | $3.25 | +423.08% | 3 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $280 → $300 | $182.22 | +64.64% | 2 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $310 → $275 | $228.92 | +20.13% | 2 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $250 | $275.14 | -9.14% | 1 | Dec 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $350 → $290 | $199.48 | +45.38% | 1 | Jul 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $42 → $46 | $14.85 | +209.76% | 5 | May 10, 2021 |
Flutter Entertainment
Nov 18, 2025
Initiates: Overweight
Price Target: $272
Current: $215.04
Upside: +26.49%
DraftKings
Nov 18, 2025
Initiates: Equal-Weight
Price Target: $31
Current: $34.46
Upside: -10.04%
Waters
Aug 5, 2025
Maintains: Hold
Price Target: $375 → $315
Current: $379.83
Upside: -17.07%
Medpace Holdings
Jul 23, 2025
Maintains: Hold
Price Target: $270 → $430
Current: $561.65
Upside: -23.44%
IQVIA Holdings
Nov 1, 2024
Maintains: Buy
Price Target: $270 → $265
Current: $225.41
Upside: +17.56%
Fortrea Holdings
Aug 20, 2024
Maintains: Hold
Price Target: $28 → $23
Current: $17.25
Upside: +33.33%
Concentra Group Holdings Parent
Aug 19, 2024
Initiates: Buy
Price Target: $29
Current: $19.68
Upside: +47.36%
10x Genomics
Jul 10, 2024
Downgrades: Hold
Price Target: $55 → $25
Current: $16.31
Upside: +53.28%
Repligen
Jun 26, 2024
Upgrades: Buy
Price Target: $180 → $155
Current: $163.86
Upside: -5.41%
Thermo Fisher Scientific
Apr 25, 2024
Maintains: Buy
Price Target: $600 → $610
Current: $579.45
Upside: +5.27%
Apr 18, 2024
Maintains: Buy
Price Target: $85 → $82
Current: $58.81
Upside: +39.43%
Apr 18, 2024
Maintains: Hold
Price Target: $23 → $25
Current: $11.46
Upside: +118.15%
Aug 8, 2023
Maintains: Buy
Price Target: $23 → $17
Current: $3.25
Upside: +423.08%
Jul 14, 2023
Maintains: Buy
Price Target: $280 → $300
Current: $182.22
Upside: +64.64%
Apr 27, 2023
Maintains: Buy
Price Target: $310 → $275
Current: $228.92
Upside: +20.13%
Dec 14, 2022
Initiates: Hold
Price Target: $250
Current: $275.14
Upside: -9.14%
Jul 14, 2022
Maintains: Buy
Price Target: $350 → $290
Current: $199.48
Upside: +45.38%
May 10, 2021
Maintains: Buy
Price Target: $42 → $46
Current: $14.85
Upside: +209.76%